EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q1 EPS of ($0.65), $0.02 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $24.45 million versus the consensus estimate of $7.87 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.